Entasis Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ENTASIS THERAP, and when can generic versions of ENTASIS THERAP drugs launch?
ENTASIS THERAP has one approved drug.
There are four US patents protecting ENTASIS THERAP drugs.
There are sixty-eight patent family members on ENTASIS THERAP drugs in forty-two countries.
Drugs and US Patents for Entasis Therap
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Entasis Therap | XACDURO (COPACKAGED) | durlobactam sodium; durlobactam sodium; sulbactam sodium | POWDER;INTRAVENOUS | 216974-001 | May 23, 2023 | RX | Yes | Yes | 9,309,245 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Entasis Therap | XACDURO (COPACKAGED) | durlobactam sodium; durlobactam sodium; sulbactam sodium | POWDER;INTRAVENOUS | 216974-001 | May 23, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
Entasis Therap | XACDURO (COPACKAGED) | durlobactam sodium; durlobactam sodium; sulbactam sodium | POWDER;INTRAVENOUS | 216974-001 | May 23, 2023 | RX | Yes | Yes | 10,376,499 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Entasis Therap Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Uruguay | 34723 | ⤷ Sign Up |
Hungary | E036722 | ⤷ Sign Up |
Spain | 2717776 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.